Literature DB >> 18032515

Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations.

María Mercedes Segura1, Alain Garnier, Marcos Rafael Di Falco, Gavin Whissell, Angélica Meneses-Acosta, Normand Arcand, Amine Kamen.   

Abstract

The Moloney murine leukemia virus (MMLV) belongs to the Retroviridae family of enveloped viruses, which is known to acquire minute amounts of host cellular proteins both on the surface and inside the virion. Despite the extensive use of retroviral vectors in experimental and clinical applications, the repertoire of host proteins incorporated into MMLV vector particles remains unexplored. We report here the identification of host proteins from highly purified retroviral vector preparations obtained by rate-zonal ultracentrifugation. Viral proteins were fractionated by one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis, in-gel tryptic digested, and subjected to liquid chromatography/tandem mass spectrometry analysis. Immunogold electron microscopy studies confirmed the presence of several host membrane proteins exposed at the vector surface. These studies led to the identification of 27 host proteins on MMLV vector particles derived from 293 HEK cells, including 5 proteins previously described as part of wild-type MMLV. Nineteen host proteins identified corresponded to intracellular proteins. A total of eight host membrane proteins were identified, including cell adhesion proteins integrin beta1 (fibronectin receptor subunit beta) and HMFG-E8, tetraspanins CD81 and CD9, and late endosomal markers CD63 and Lamp-2. Identification of membrane proteins on the retroviral surface is particularly attractive, since they can serve as anchoring sites for the insertion of tags for targeting or purification purposes. The implications of our findings for retrovirus-mediated gene therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032515      PMCID: PMC2224463          DOI: 10.1128/JVI.01909-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4.

Authors:  Z Liao; J W Roos; J E Hildreth
Journal:  AIDS Res Hum Retroviruses       Date:  2000-03-01       Impact factor: 2.205

2.  Actin-binding cellular proteins inside human immunodeficiency virus type 1.

Authors:  D E Ott; L V Coren; D G Johnson; B P Kane; R C Sowder; Y D Kim; R J Fisher; X Z Zhou; K P Lu; L E Henderson
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

3.  Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell.

Authors:  Y Takeuchi; F L Cosset; P J Lachmann; H Okada; R A Weiss; M K Collins
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Identification, proteomic profiling, and origin of ram epididymal fluid exosome-like vesicles.

Authors:  Jean-Luc Gatti; Sonia Métayer; Maya Belghazi; Françoise Dacheux; Jean-Louis Dacheux
Journal:  Biol Reprod       Date:  2005-01-05       Impact factor: 4.285

5.  Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells.

Authors:  H Hanenberg; X L Xiao; D Dilloo; K Hashino; I Kato; D A Williams
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

6.  Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments.

Authors:  T Moritz; P Dutt; X Xiao; D Carstanjen; T Vik; H Hanenberg; D A Williams
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

7.  Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.

Authors:  L O Arthur; J W Bess; R C Sowder; R E Benveniste; D L Mann; J C Chermann; L E Henderson
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

8.  Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation.

Authors:  Richard Wubbolts; Rachel S Leckie; Peter T M Veenhuizen; Guenter Schwarzmann; Wiebke Möbius; Joerg Hoernschemeyer; Jan-Willem Slot; Hans J Geuze; Willem Stoorvogel
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

9.  Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity.

Authors:  J S Paquette; J F Fortin; L Blanchard; M J Tremblay
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73.

Authors:  C Théry; A Regnault; J Garin; J Wolfers; L Zitvogel; P Ricciardi-Castagnoli; G Raposo; S Amigorena
Journal:  J Cell Biol       Date:  1999-11-01       Impact factor: 10.539

View more
  27 in total

1.  A Proteomics Survey of Junín Virus Interactions with Human Proteins Reveals Host Factors Required for Arenavirus Replication.

Authors:  Christopher M Ziegler; Philip Eisenhauer; Jamie A Kelly; Loan N Dang; Vedran Beganovic; Emily A Bruce; Benjamin R King; David J Shirley; Marion E Weir; Bryan A Ballif; Jason Botten
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

2.  Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity.

Authors:  Jae-Min Song; Chi-Won Choi; Sang-Oh Kwon; Richard W Compans; Sang-Moo Kang; Seung Il Kim
Journal:  J Proteome Res       Date:  2011-07-08       Impact factor: 4.466

3.  Proteomics of the Autographa californica nucleopolyhedrovirus budded virions.

Authors:  Ranran Wang; Fei Deng; Dianhai Hou; Yong Zhao; Lin Guo; Hualin Wang; Zhihong Hu
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

4.  Maturation of the Gag core decreases the stability of retroviral lipid membranes.

Authors:  Candice Davidoff; Riley J Payne; Sharon H Willis; Benjamin J Doranz; Joseph B Rucker
Journal:  Virology       Date:  2012-09-17       Impact factor: 3.616

5.  Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.

Authors:  Christelle Brégnard; Alessia Zamborlini; Marjorie Leduc; Philippe Chafey; Luc Camoin; Ali Saïb; Serge Benichou; Olivier Danos; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

6.  Proteomic analysis of purified coronavirus infectious bronchitis virus particles.

Authors:  Qingming Kong; Chunyi Xue; Xiangpeng Ren; Chengwen Zhang; Linlin Li; Dingming Shu; Yingzuo Bi; Yongchang Cao
Journal:  Proteome Sci       Date:  2010-06-09       Impact factor: 2.480

7.  Galectin-1 interacts with the human endogenous retroviral envelope protein syncytin-2 and potentiates trophoblast fusion in humans.

Authors:  Caroline Toudic; Amandine Vargas; Yong Xiao; Guillaume St-Pierre; Norbert Bannert; Julie Lafond; Éric Rassart; Sachiko Sato; Benoit Barbeau
Journal:  FASEB J       Date:  2019-09-07       Impact factor: 5.191

8.  P64, a novel major virion DNA-binding protein potentially involved in condensing the Spodoptera frugiperda Ascovirus 1a genome.

Authors:  Yeping Tan; Tatsinda Spears; Dennis K Bideshi; Jeffrey J Johnson; Robert Hice; Yves Bigot; Brian A Federici
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

9.  The proteome of the infectious bronchitis virus Beau-R virion.

Authors:  Stuart D Dent; Dong Xia; Jonathan M Wastling; Benjamin W Neuman; Paul Britton; Helena J Maier
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

10.  Analysis of virion associated host proteins in vesicular stomatitis virus using a proteomics approach.

Authors:  Megan Moerdyk-Schauwecker; Sun-Il Hwang; Valery Z Grdzelishvili
Journal:  Virol J       Date:  2009-10-12       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.